SCB-1019

SCB-1019 · Clover Biopharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SCB-1019, covering 2025-06-06 to 2025-06-06. Get the full timeline:

Most recent: Clinical Trial Update: First-in-human Safety and Immunogenicity Study of SCB-1019 and SCB-1019T in Healthy Adults [Phase 1]